RIBS IV (Restenosis Intra-stent of Drug-eluting Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent). A Prospective, Multicenter and Randomized Clinical Trial

Trial Profile

RIBS IV (Restenosis Intra-stent of Drug-eluting Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent). A Prospective, Multicenter and Randomized Clinical Trial

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Everolimus (Primary) ; Paclitaxel (Primary)
  • Indications Coronary artery restenosis
  • Focus Therapeutic Use
  • Acronyms RIBS-IV
  • Most Recent Events

    • 05 Jan 2017 Results (n=249) of pooled analysis of RIBS IV and RIBS V studies assessing the safety and efficacy of DEB in patients with ISR, published in the American Journal of Cardiology
    • 08 Dec 2015 Results (pooled analysis of RIBS IV and RIBS V trials) published in the American Journal of Cardiology (n = 442).
    • 24 Nov 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top